Santos Ltd reveals massive loss at half year, should you sell?

Here's what Santos Ltd (ASX:STO) had to say about its results for the half-year to June 30.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Like fellow oil & gas producer Woodside Petroleum Limited (ASX: WPL), Santos Ltd (ASX: STO) also reported hefty declines in revenue and profits today. Unlike Woodside, Santos doesn't appear to be a viable investment today – unless you believe oil prices are set to rise.

Here's what you need to know:

  • Revenues fell 6% to $1,191 million
  • Net Profit After Tax fell 3,780% to a loss of $1,104 million
  • Underlying Net Profit After Tax fell $30 million to a loss of $5 million
  • Production rose 10% to 31.1 million barrels of oil equivalent ("mmboe")
  • $1.5 billion write-down on Gladstone LNG plant
  • Unit production costs fell* 15% to $8.8/barrel of oil equivalent ("boe")
  • Net debt reduced to $4.5 billion, nearest maturity in 2019
  • Guidance maintained at 57-63 mmboe production for full year
  • Targeting under US$40/barrel break-even level in the future

So What?

Things didn't get off to a good start for Santos in the first half, with the average realised price diving to $42.79/barrel, well below the group's break-even level of $47/barrel. Santos is targeting a break-even price of $43.50 per barrel for the full year 2016, but even this may not be enough if current prices persist.

Santos has also slashed its capital expenditure budget, and an interesting chart of safety performance and total hours worked (by employees and contractors) show the company's evolution over the last couple of years with the ramp up of GLNG and subsequent decline in oil prices.

source: Company presentation
source: Company presentation

The group made a small dent in its $4.5 billion pile of debt during the year, but with limited cash flows (due to low oil prices) and ongoing expenditure required, Santos is far from out of the woods. Notably, although it has potential to lift sales through its second LNG train at the Gladstone project, the recent $1.5 billion write-down of the GLNG asset shows that future earnings expectations from this business have been reduced.

Now What?

Unlike peer Woodside Petroleum, Santos doesn't really have the ability to buy growth via acquisition. Although management states it does have several billion dollars in available liquidity if necessary, this is not something that is likely to be spent while the company operates at below break-even prices.

Santos receives an increase of $30 million in operating cash flow for every US$1/barrel improvement in the oil price, and as such is well leveraged to rising oil prices. As a result I feel that any decision to purchase Santos is an implicit bet on the value of oil and gas prices – and this is not something done without thought.

The oil market

I wrote an article in December about how investors in oil shares were  headed for disappointment in 2016. Although many companies stand to benefit significantly from higher oil prices, investors must contrast the scale of the gains that could be made with the likelihood of them occurring.

There are no guarantees that oil will head back to US$100/barrel, for example. Although it's all we've known for most of the last 15 years, over the longer term $100 oil looks more like an anomaly than a benchmark. Investors looking to make money in oil should consider a number of factors including the US rig count, as well as the regular updates from the International Energy Agency (IEA) and OPEC which are often widely covered in the financial media.

Although Santos does have attractive upside if oil prices rebound, I haven't seen any real evidence that this could be about to happen (sustainably). What investors are left with is a heavily indebted company trying to grind its cost of production down to fit underneath the value of its sales, which is not a sexy investment case.

I prefer Woodside Petroleum Limited (ASX:WPL) today.

Motley Fool contributor Sean O'Neill has no position in any stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »